173 related articles for article (PubMed ID: 37742009)
1. DSCC1 interacts with HSP90AB1 and promotes the progression of lung adenocarcinoma via regulating ER stress.
Lin X; Liu YH; Zhang HQ; Wu LW; Li Q; Deng J; Zhang Q; Yang Y; Zhang C; Li YL; Hu J
Cancer Cell Int; 2023 Sep; 23(1):208. PubMed ID: 37742009
[TBL] [Abstract][Full Text] [Related]
2. High DSCC1 Level Predicts Poor Prognosis of Lung Adenocarcinoma.
Chang S; Zhu Y; Xi Y; Gao F; Lu J; Dong L; Ma C; Li H
Int J Gen Med; 2021; 14():6961-6974. PubMed ID: 34707388
[TBL] [Abstract][Full Text] [Related]
3. Effect of Upregulated DNA Replication and Sister Chromatid Cohesion 1 Expression on Proliferation and Prognosis in Hepatocellular Carcinoma.
Xie XW; Wang XY; Liao WJ; Fei R; Cong X; Chen Q; Wei L; Chen HS; Wang Y
Chin Med J (Engl); 2018 Dec; 131(23):2827-2835. PubMed ID: 30511685
[TBL] [Abstract][Full Text] [Related]
4. AIM2 upregulation promotes metastatic progression and PD-L1 expression in lung adenocarcinoma.
Zheng JQ; Lin CH; Lee HH; Chang WM; Li LJ; Su CY; Lee KY; Chiu HW; Lin YF
Cancer Sci; 2023 Jan; 114(1):306-320. PubMed ID: 36104978
[TBL] [Abstract][Full Text] [Related]
5. DNA Replication and Sister Chromatid Cohesion 1 (DSCC1) of the Replication Factor Complex CTF18-RFC is Critical for Colon Cancer Cell Growth.
Kim JT; Cho HJ; Park SY; Oh BM; Hwang YS; Baek KE; Lee YH; Kim HC; Lee HG
J Cancer; 2019; 10(24):6142-6153. PubMed ID: 31762824
[TBL] [Abstract][Full Text] [Related]
6. Serum exosomal miR-16-5p functions as a tumor inhibitor and a new biomarker for PD-L1 inhibitor-dependent immunotherapy in lung adenocarcinoma by regulating PD-L1 expression.
Chen HL; Luo YP; Lin MW; Peng XX; Liu ML; Wang YC; Li SJ; Yang DH; Yang ZX
Cancer Med; 2022 Jul; 11(13):2627-2643. PubMed ID: 35347894
[TBL] [Abstract][Full Text] [Related]
7. Alpha5 nicotinic acetylcholine receptor mediated immune escape of lung adenocarcinoma via STAT3/Jab1-PD-L1 signalling.
Zhu P; Jin Z; Kang G; Jia Y; Liu D; Zhang Q; Guo F; Jia Y; Jiao Y; Li J; Sun H; Ma X
Cell Commun Signal; 2022 Aug; 20(1):121. PubMed ID: 35971127
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of cohesion establishment factor DSCC1 through E2F in colorectal cancer.
Yamaguchi K; Yamaguchi R; Takahashi N; Ikenoue T; Fujii T; Shinozaki M; Tsurita G; Hata K; Niida A; Imoto S; Miyano S; Nakamura Y; Furukawa Y
PLoS One; 2014; 9(1):e85750. PubMed ID: 24465681
[TBL] [Abstract][Full Text] [Related]
9. EEF1A2 interacts with HSP90AB1 to promote lung adenocarcinoma metastasis via enhancing TGF-β/SMAD signalling.
Jia L; Ge X; Du C; Chen L; Zhou Y; Xiong W; Xiang J; Li G; Xiao G; Fang L; Li Z
Br J Cancer; 2021 Mar; 124(7):1301-1311. PubMed ID: 33473168
[TBL] [Abstract][Full Text] [Related]
10. The α5-nAChR/PD-L1 axis facilitates lung adenocarcinoma cell migration and invasion.
Zhu P; Kang G; Jiao Y; Gui C; Fan H; Li X; Jia Y; Zhang L; Ma X
Hum Cell; 2022 Jul; 35(4):1207-1218. PubMed ID: 35593989
[TBL] [Abstract][Full Text] [Related]
11. DNA replication and sister chromatid cohesion 1 promotes breast carcinoma progression by modulating the Wnt/β-catenin signaling and p53 protein.
Jin G; Wang W; Cheng P; Tian Y; Zhang L; Niu HU
J Biosci; 2020; 45():. PubMed ID: 33184243
[TBL] [Abstract][Full Text] [Related]
12. Identification of eIF6 as a prognostic factor that drives tumor progression and predicts arsenic trioxide efficacy in lung adenocarcinoma.
Shen Y; Zhang R; Li X
Mol Biol Rep; 2023 Feb; 50(2):1167-1180. PubMed ID: 36435920
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of ERCC6L correlates with poor prognosis and confers malignant phenotypes of lung adenocarcinoma.
Huang X; Jiang L; Lu S; Yuan M; Lin H; Li B; Wen Z; Zhong Y
Oncol Rep; 2022 Jul; 48(1):. PubMed ID: 35656882
[TBL] [Abstract][Full Text] [Related]
14. NPM3 as a novel oncogenic factor and poor prognostic marker contributes to cell proliferation and migration in lung adenocarcinoma.
Wei S; Xing J; Lu K; Wang K; Yu W
Hereditas; 2023 May; 160(1):27. PubMed ID: 37254219
[TBL] [Abstract][Full Text] [Related]
15. ADAR1 is a prognostic biomarker and is correlated with immune infiltration in lung adenocarcinoma.
Yang W; Chen K; Yu Q; Liao R; He H; Peng Y; Yang Z; Zhang X
Cancer Med; 2023 Jul; 12(13):14820-14832. PubMed ID: 37162299
[TBL] [Abstract][Full Text] [Related]
16. H3K4me3-related lncRNAs signature and comprehensive analysis of H3K4me3 regulating tumor immunity in lung adenocarcinoma.
Fan T; Zhu M; Muhammad S; Xiao C; Li S; Tian H; Liu Y; Xue L; Zheng B; Li C; He J
Respir Res; 2023 May; 24(1):122. PubMed ID: 37131252
[TBL] [Abstract][Full Text] [Related]
17. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Li N; Li Y; Zheng P; Zhan X
Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
[TBL] [Abstract][Full Text] [Related]
18. MAX transcriptionally enhances PD-L1 to inhibit CD8+ T cell-mediated killing of lung adenocarcinoma cells.
Huang D; Wang X; Qian Y; Wu J; Chen B; Zhang D; Dong F; Li Y
Cell Immunol; 2023 Apr; 386():104706. PubMed ID: 36931054
[TBL] [Abstract][Full Text] [Related]
19. CKS2 Overexpression Correlates with Prognosis and Immune Cell Infiltration in Lung Adenocarcinoma: A Comprehensive Study based on Bioinformatics and Experiments.
Wang Z; Zhang M; Wu Y; Yu Y; Zheng Q; Li J
J Cancer; 2021; 12(23):6964-6978. PubMed ID: 34729099
[No Abstract] [Full Text] [Related]
20. Deubiquitinase JOSD1 promotes tumor progression via stabilizing Snail in lung adenocarcinoma.
Ma X; Qi W; Yang F; Pan H
Am J Cancer Res; 2022; 12(5):2323-2336. PubMed ID: 35693075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]